Search results for: 'capture document processing'
- Related search terms
- document management systems
- Processing Self Service
- document management europe
- Documentation from the admitting physician is insufficient to determine if condition is present on admission.
- processing ad part ad cancer
-
24 Nov 2021  |  Global  |  Technology Research
Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies
Need for Scalable, Reproducible, and Cost-Effective Manufacturing Processes Driving Growth Opportunities
The Frost & Sullivan research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, there is a huge capacity deficit that the industry is collaboratively trying to address. Scalability, costs, reproducibility, and overall process ef...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Jun 2021  |  Global  |  Frost Radar
Frost Radar™: Artificial Intelligence-enabled Drug Discovery in the Global Pharmaceutical Industry, 2021
A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Jun 2019  |  Global  |  Technology Research
Technologies Transforming the Biomanufacturing Landscape
Translating Technology Innovation to Market Competitiveness
Overall Impact of Biomanufacturing Technology Innovations Impact on Unmet Needs Pharmaceutical companies perceive analytical services as important. There is a need for a robust platform that enables the provision of such services. Pharma firms are outsourcing crucial processes and are utilizing services such as analytics, research, process developm...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Nov 2021  |  Global  |  Market Research
Global Pharmaceutical Packaging Growth Opportunities
The Growing Pipeline of Temperature-sensitive Biologics Products and Healthcare Stakeholders’ Higher Stake in Patient Health Outcomes will Drive Investments
The COVID-19 pandemic has not only revealed supply chain challenges in terms of meeting pandemic-induced demand but also showcased weaknesses with regard to facing disruptions on a global scale. Immediate impacts include supply volatility, steep price increases, and high levels of uncertainty. Despite the manufacturing reboot, supply chain inter...
$2,450.00
Special Price $1,837.50 save 25 %
-
10 May 2023  |  Global  |  Market Research
Growth Opportunities in the Biologics Contract Development and Manufacturing Organization Sector
Value Chain Expansion to Support Next generation Biologics Drives Future Growth Potential
This research service provides an overview of the global biologics contract development and manufacturing organization (bio-CDMO) market and a 6-year market revenue forecast (2023 to 2028). The geographic scope covers three key regions, namely North America (NA); Europe; and Asia-Pacific (APAC). The report offers a detailed segment analysis of...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Oct 2020  |  Global  |  Market Research
Supply Chain Optimization and Decentralized Manufacturing to Expand the Contract Cell and Gene Therapy Manufacturing Market, 2020–2026
Automation Deployed to Contain Cost of Goods Sold and Vector Manufacturing Standardization will Create New Growth Opportunities
The cell and gene therapy segment is one of the fastest growing segments in the biopharmaceutical space. While the science behind the therapy has grown by leaps and bounds on the back of decades worth of research, manufacturing has unfortunately lagged behind. To fully harness the curative potential of these therapies and ensure greater reach and a...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Nov 2021  |  Global  |  Technology Research
Targeted Immunotherapy in Oncology
Developments in Biotechnology Platforms Leading to Increasing Immuno-oncology Applications
This research service investigates technologies that propel the development of new targeted immunotherapies, particularly those that deliver therapeutic DNA and proteins. The top 3 growth opportunities focus on enhanced gene delivery systems for greater precision, the support of such systems through novel biotech platforms, and the affordability of...
$4,950.00
Special Price $3,712.50 save 25 %
-
26 Sep 2019  |  Global  |  Market Research
Growth Insight—Role of AI in the Pharmaceutical Industry, Global, 2018–2022
Exploring Key Investment Trends, Companies-to-Action, and Growth Opportunities for AI in the Pharmaceutical Industry
Pharmaceutical drug discovery and development processes suffer from declining success rates and a stagnant pipeline. Artificial Intelligence (AI) supported by Big Data could be a key element that can provide an effectual solution. There has been a rapid growth in the data generated within the life sciences and pharmaceutical industries. This stems ...
$4,950.00
Special Price $3,712.50 save 25 %
-
05 Jun 2018  |  Global  |  Market Research
Anti-Aging Therapies and Services Market—Trends and Growth Opportunities, Forecast to 2022
Focus on Integrative Solutions Combining Dietary Supplements and Aesthetic Solutions with Clinical Therapeutics as the Market Moves Toward a ‘Prevent-Manage-Repair’ Continuum
The rapidly aging global population is placing immense pressure on healthcare systems across countries and regions. The improvement in life expectancy levels has created a large cohort of aged patients who suffer from one or more chronic diseases. Traditionally, the approach towards the management of this issue has been on ‘repair’, i.e., treatment...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Jun 2024  |  Global  |  Market Research
Growth Opportunities in Biologics Contract Development and Manufacturing Organizations, 2024 2029
Risk-sharing Business Models for Next-generation Biologics Will Drive Bio-CDMO Growth and Spur Future Potential
By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...
$4,950.00
Special Price $3,712.50 save 25 %